Pr ecis: This study offers a preclinical rationale for coadministering immune checkpoint therapies with cancer vaccines to vastly empower their efficacy, with major implications for the broader and more effective application of active immunotherapy in treating malignancy.
Pr ecis: Aspirin use may protect against lymph node involvement in breast cancer, making a diagnosis of earlystage curable disease more likely even in the absence of general chemopreventive effects.
4078
Recent ABOUT THE COVER Induced PDL1 expression in the tumor microenvironment can be abrogated with neutralizing antibodies against IFNg. In the B16 model, TLR4/7/8 agonists-formulated tumor vaccine increased antitumor CTL response that correlated with increased tumor infiltrating T cells and increased PDL1 expression in the tumor microenvironment. This induction of PDL1 was found to be IFNg dependent as shown. When combining PDL1-inducing vaccine with PD1 blocking antibody, regression of established tumors was found. For details, see article by Fu and colleagues on page 4042.
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